Drug Trial Radar · NCT04354545
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Apr 1, 2021
Primary completion
Dec 1, 2026
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- University of California, Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bausch & Lomb Incorporated
- First posted
- Apr 21, 2020
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Conditions
- Glaucoma
- Ocular Surface Disease
Interventions
Xiidra (Lifitegrast ophthalmic solution) 5%Drug
FDA approved lifitegrast opthalmic solution eye drop
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to week 12 in corneal fluorescein staining scoreTime frame: From baseline to Week 12
- Change from baseline to week 12 in eye dryness score (EDS)Time frame: From baseline to Week 12
- Change from baseline to week 12 in ocular surface disease index (OSDI) questionnaire scoreTime frame: From baseline to Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Doheny Eye Center UCLA
Fountain Valley, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.